These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2033586)

  • 1. Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2',3'-dideoxypurine nucleosides.
    Murakami K; Shirasaka T; Yoshioka H; Kojima E; Aoki S; Ford H; Driscoll JS; Kelley JA; Mitsuya H
    J Med Chem; 1991 May; 34(5):1606-12. PubMed ID: 2033586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipophilic halogenated congeners of 2',3'-dideoxypurine nucleosides active against human immunodeficiency virus in vitro.
    Shirasaka T; Murakami K; Ford H; Kelley JA; Yoshioka H; Kojima E; Aoki S; Broder S; Mitsuya H
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9426-30. PubMed ID: 2251284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system targeting of 2',3'-dideoxyinosine via adenosine deaminase-activated 6-halo-dideoxypurine prodrugs.
    Morgan ME; Chi SC; Murakami K; Mitsuya H; Anderson BD
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2156-65. PubMed ID: 1444295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antiviral (HIV-1, HBV) activities of 5-halo-6-methoxy(or azido)-5,6-dihydro-3'-fluoro-3'-deoxythymidine diastereomers. Potential prodrugs to 3'-fluoro-3'-deoxythymidine.
    Kumar R; Wang L; Wiebe LI; Knaus EE
    J Med Chem; 1994 Oct; 37(21):3554-60. PubMed ID: 7932583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential anti-AIDS drugs. Lipophilic, adenosine deaminase-activated prodrugs.
    Barchi JJ; Marquez VE; Driscoll JS; Ford H; Mitsuya H; Shirasaka T; Aoki S; Kelley JA
    J Med Chem; 1991 May; 34(5):1647-55. PubMed ID: 2033591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 2. 6-Halo and 6-alkoxy prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosine.
    Ford H; Siddiqui MA; Driscoll JS; Marquez VE; Kelley JA; Mitsuya H; Shirasaka T
    J Med Chem; 1995 Mar; 38(7):1189-95. PubMed ID: 7707321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 3. 6-Amino prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosine.
    Driscoll JS; Siddiqui MA; Ford H; Kelley JA; Roth JS; Mitsuya H; Tanaka M; Marquez VE
    J Med Chem; 1996 Apr; 39(8):1619-25. PubMed ID: 8648601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, in vitro biological stability, and anti-HIV activity of 5-halo-6-alkoxy(or azido)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs to 3'-azido-3'-deoxythymidine (AZT).
    Kumar R; Wang L; Wiebe LI; Knaus EE
    J Med Chem; 1994 Dec; 37(25):4297-306. PubMed ID: 7996541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption and intestinal metabolism of purine dideoxynucleosides and an adenosine deaminase-activated prodrug of 2',3'-dideoxyinosine in the mesenteric vein cannulated rat ileum.
    Singhal D; Ho NF; Anderson BD
    J Pharm Sci; 1998 May; 87(5):569-77. PubMed ID: 9572907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological behaviour of 6-chloro-2',3'-dideoxyguanosine and 6-chloro-2',3'-dideoxyinosine in the brains of mice.
    Fujii Y; Kojima E; Ohtani I; Mukai R; Murakami K; Yoshikawa Y
    Nucleic Acids Symp Ser; 1997; (37):173-4. PubMed ID: 9586055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 6-alkoxypurine 2',3'-dideoxynucleosides as inhibitors of the cytopathic effect of the human immunodeficiency virus.
    Burns CL; St Clair MH; Frick LW; Spector T; Averett DR; English ML; Holmes TJ; Krenitsky TA; Koszalka GW
    J Med Chem; 1993 Feb; 36(3):378-84. PubMed ID: 8426365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and selective activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside, 3'-fluoro-2,6-diaminopurine-2',3'-dideoxyriboside, and 3'-fluoro-2',3'-dideoxyguanosine against human immunodeficiency virus.
    Balzarini J; Baba M; Pauwels R; Herdewijn P; Wood SG; Robins MJ; de Clercq E
    Mol Pharmacol; 1988 Mar; 33(3):243-9. PubMed ID: 3258404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo biodistribution, pharmacokinetic parameters, and brain uptake of 5-halo-y-methoxy(or ethoxy)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs of 3'-azido-3'-deoxythymidine.
    Wang L; Morin KW; Kumar R; Cheraghali M; Todd KG; Baker GB; Knaus EE; Wiebe LI
    J Med Chem; 1996 Feb; 39(4):826-33. PubMed ID: 8632406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of the SOS response in Escherichia coli by azidothymidine and dideoxynucleosides.
    Mamber SW; Brookshire KW; Forenza S
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1237-43. PubMed ID: 2118327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationships of 6-substituted 2',3'-dideoxypurine nucleosides as potential anti-human immunodeficiency virus agents.
    Chu CK; Ullas GV; Jeong LS; Ahn SK; Doboszewski B; Lin ZX; Beach JW; Schinazi RF
    J Med Chem; 1990 Jun; 33(6):1553-61. PubMed ID: 2342052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of lipophilic 6-halo-2',3'-dideoxypurine nucleoside and derivatives: approach to develop CNS-targeting anti-HIV agents].
    Murakami K; Kojima E; Kojima E; Shirasaka T; Mitsuya H
    Nihon Rinsho; 1993 Sep; 51 Suppl():132-8. PubMed ID: 8271376
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
    Singhal D; Morgan ME; Anderson BD
    Drug Metab Dispos; 1996 Oct; 24(10):1155-61. PubMed ID: 8894519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of dideoxypurine nucleoside analogs in plasma and cerebrospinal fluid of rhesus monkeys.
    Hawkins ME; Mitsuya H; McCully CM; Godwin KS; Murakami K; Poplack DG; Balis FM
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1259-64. PubMed ID: 7574512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced oral bioavailability of DDI after administration of 6-Cl-ddP, an adenosine deaminase-activated prodrug, to chronically catheterized rats.
    Anderson BD; Morgan ME; Singhal D
    Pharm Res; 1995 Aug; 12(8):1126-33. PubMed ID: 7494823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-2',3'-dideoxyadenosine derivatives.
    Haertle T; Carrera CJ; Wasson DB; Sowers LC; Richman DD; Carson DA
    J Biol Chem; 1988 Apr; 263(12):5870-5. PubMed ID: 3258602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.